Germ Patrol achieved phenomenal success in Japan, becoming the best-selling new sanitizer with $40 million in sales in its first year. Sold under the names "Mold Cut" and "Novi Guard," the product was licensed to a Japanese company and shipped in 55-gallon drums to be repackaged into plastic bottles by a local manufacturer for distribution.
A customer enhanced the Mummy Sleeping Bag's features by incorporating Germ Patrol Anti-microbial additive into production in China. As a result, the final product became mold, mildew-resistant, and germ-free.
Germ Pro, alongside the hospital's existing infection prevention strategies, slashed healthcare-associated infections (HAIs) by 27.6%. Notably, Methicillin-resistant Staphylococcus aureus (MRSA) decreased by 44.9% and Clostridium difficile (C. difficile) by 37.8%, according to Grace. While CDC guidelines emphasize hand hygiene and surface disinfection, Grace highlighted Germ Pro's unique advantage: its persistent killing power between cleanings, which inhibits germ spread effectively.
Novartis Pharmaceuticals conducted tests of Germ Patrol in notoriously dirty environments: a pig pen and a chicken coop. The Novartis scientist described the results as "amazing," noting that Germ Patrol transformed these filthy spaces into conditions clean enough for surgery to be performed on the floor.
Unveiling the Untold: The Astonishing Account Overlooked by Mainstream Media, including the Wall Street Journal, Arizona Republic, and Network Television. Delve into the Documented Chronicle of a Remarkable Drug, Hailed by Wall Street Analysts as the Next Frontier in Cutting-Edge Technology